A vaccine for dengue fever, an advanced therapy for a complication after transplants, and a potential first-in-class drug for a form of psoriasis were among medicines recommended for approval by European regulators on Oct. 14. Read More
South Korea's LG Chem Ltd., seeking new growth opportunities in the life sciences and a concrete footprint in the U.S., has proposed an all-cash acquisition of Aveo Pharmaceuticals Inc., with a deal value of $519.2 million. Read More
Nanjing Iaso Biotherapeutics Co. Ltd. has out-licensed a fully human anti-CD19 binder to Cabaletta Bio Inc. in a deal worth up to $162 million. Read More
Worg Pharmaceuticals Co. Ltd. raised nearly ¥400 million (US$55.6 million) in its series B financing. Founded in 2018, the company is developing immunotherapies to treat allergic and autoimmune diseases and other indications based on its two technology platforms, Pcfit and Apitope. Read More
PT Etana Biotechnologies Indonesia secured a series B financing of undisclosed value, led by Chinese investors that include Jack Ma’s Yunfeng Capital and Highlight Capital. The funds will be used to strengthen the company's pipeline and to expand its local manufacturing capacity. Read More
South Korea’s drug regulator should consider revising orphan drug definitions or allow more new innovative drugs to be excluded from pharmacoeconomic assessments, which are required for new drugs to be reimbursed under Korea’s single-payer system, the European Chamber of Commerce in Korea said. Read More
Australia’s TGA has opened a consultation on drug-device combination products to help sponsors understand the regulatory pathway through which their products will likely pass since these combination products may not fit within existing definitions for drugs, biologicals or medical devices. Read More
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Accutar, Actinogen Medical, Alterity, Ascletis, Beigene, Biontech, Bio-Thera Solutions, Hutchmed, Junshi, Moleculin, Novavax, Nuance, Pfizer, Verona. Read More
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Adalta, Cabaletta, Cocrystal, Genuv, GPCR, Iaso, Jacobio, Merck KGaA, Moderna, Oncotelic, Toregem, Wuxi Biologics. Read More
